26.03.2019 • NewsElaine BurridgeInvistaPTA

Invista in First PTA License in Middle East

Invista in First PTA License in Middle East
Invista in First PTA License in Middle East

Invista’s technology and licensing arm, Invista Performance Technologies, has agreed to supply its PTA technology to Pan-Asia PET Resin (Guangzhou province, China) for a new plant to be built in Saudi Arabia. The deal marks the first technology license for Invista in the Middle East.

Pan-Asia will use the P8 PTA process technology for a 1.25 million t/y plant to be built in Jizan Economic City. The targeted start-up date is for the first quarter of 2021.

In separate news, Fluor has started pre-front-end engineering and design (pre-FEED) and FEED work for Invista’s proposed adiponitrile (ADN) plant in China. The US contractor said it will be the first world-scale ADN facility to be built in more than 35 years.

Located at the Shanghai Chemical Industry Park, the plant will produce around 400,000 t/y of the intermediate, which is used to make nylon polymers, fibers and other specialty materials.

Fluor’s Shanghai office will lead the project work. Construction is scheduled to start in 2020 and start-up is expected to begin by 2022.

Speaking last December, at the 16th China International Polyamide & Intermediates Forum, Kyle Redinger, chairman of Invista (China) Investment and vice president of Invista Intermediates, estimated that China could be the world’s largest market for nylon in the next five years. “We believe it’s important to serve China from China to realize the full potential of the market,” he said.

With an investment in excess of $1 billion in the new ADN plant, he said Invista will have spent more than $2 billion over 10 years in its global nylon 6,6 chain when the China plant is complete.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.